| Mrs Stephanie Catherine Vidaurri, LCSW | |
|
498 Chalan Palosyo, Guam Va Cboc, Agana Heights, GU 96910-6427 | |
| (671) 475-5800 | |
| Not Available |
| Full Name | Mrs Stephanie Catherine Vidaurri |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 498 Chalan Palosyo, Agana Heights, Guam |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790121176 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | LCSW 3734 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Stephanie Catherine Vidaurri, LCSW 8 Anae Ln, Santa Rita, GU 96915-1433 Ph: (671) 564-1789 | Mrs Stephanie Catherine Vidaurri, LCSW 498 Chalan Palosyo, Guam Va Cboc, Agana Heights, GU 96910-6427 Ph: (671) 475-5800 |
News Archive
Watson Pharmaceuticals, Inc. has confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its Levonorgestrel and Ethinyl Estradiol tablets, USP (0.09 mg/0.02 mg) extended-cycle oral contraceptive product prior to the expiration of patents owned by Wyeth.
Patients in the intensive care unit who do not tolerate adequate nutrition from tube feeding should wait a week before receiving intravenous (IV) feeding because, compared with early IV feeding, it enhances recovery from critical illness.
The U.S. Food and Drug Administration today expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer, and it is the first time any drug has been approved to treat certain patients with metastatic breast cancer who have a "BRCA" gene mutation.
Labopharm Inc. today announced the U.S. Food and Drug Administration (FDA) has approved OLEPTRO(TM) (trazodone hydrochloride) Extended Release Tablets, a novel once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults. OLEPTRO(TM) utilizes CONTRAMID(R), Labopharm's clinically validated technology that controls the release of active substances within oral medications.
"As the world's worst outbreak of cholera continues to ravage Haiti, international donors have averted their gaze," a Washington Post editorial writes. The editorial notes that a "pilot project to vaccinate Haitians against the disease ... reached only one percent of the population, with no immediate prospect of expansion," and "of the 100 or so cholera treatment centers that sprang up around the country after the disease was detected 19 months ago, fewer than a third remain."
› Verified 3 days ago
Mrs. Rosita Aguilo Mahony, LCSW, BCD Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Farenholt Street, Building K-1, Agana Heights, GU 96919 Phone: 671-344-9401 Fax: 671-344-9522 | |
Laura B Snell, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 498 Chalan Palosyo, Agana Heights, GU 96910 Phone: 508-801-9725 | |
Norma Consuelo Shryock, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Bldg 1 Farenholt Avenue, Agana Heights, GU 96910 Phone: 671-344-7550 Fax: 671-344-9597 | |
Christina Sablan Leon Guerrero, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 498 Chalan Palosyo, Agana Heights, GU 96910 Phone: 671-475-0061 | |
Nikima Tangerine Loureiro, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Bldg #50, Farenholt Ave,, Agana Heights, GU 96910 Phone: 671-344-9401 | |
Lovelle L Baza, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 498 Chalan Palosyo, Agana Heights, GU 96910 Phone: 671-687-1551 |